Biblio
Export 102 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is Q [Clear All Filters]
“Within-Individual Variability: An Index for Subtle Change in Neurocognition in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 54, no. 1, pp. 325-35, 2016.
, “Altered Gut Microbiota in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1241-1257, 2017.
, “Amylin Enhances Amyloid-β Peptide Brain to Blood Efflux Across the Blood-Brain Barrier.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1087-1099, 2017.
, “Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 56, no. 1, pp. 47-61, 2017.
, “Colivelin Ameliorates Impairments in Cognitive Behaviors and Synaptic Plasticity in APP/PS1 Transgenic Mice.”, J Alzheimers Dis, vol. 59, no. 3, pp. 1067-1078, 2017.
, “Colivelin Ameliorates Impairments in Cognitive Behaviors and Synaptic Plasticity in APP/PS1 Transgenic Mice.”, J Alzheimers Dis, vol. 59, no. 3, pp. 1067-1078, 2017.
, “Dickkopf 3 (Dkk3) Improves Amyloid-β Pathology, Cognitive Dysfunction, and Cerebral Glucose Metabolism in a Transgenic Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 2, pp. 733-746, 2017.
, “The Effects of LW-AFC on the Hippocampal Transcriptome in Senescence-Accelerated Mouse Prone 8 Strain, a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 1, pp. 227-240, 2017.
, “Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer's Disease and Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 58, no. 2, pp. 413-423, 2017.
, “MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1223-1233, 2017.
, “mTORC2 (Rictor) in Alzheimer's Disease and Reversal of Amyloid-β Expression-Induced Insulin Resistance and Toxicity in Rat Primary Cortical Neurons.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1015-1036, 2017.
, “A Novel PSEN1 K311R Mutation Discovered in Chinese Families with Late-Onset Alzheimer's Disease Affects Amyloid-β Production and Tau Phosphorylation.”, J Alzheimers Dis, vol. 57, no. 2, pp. 613-623, 2017.
, “Odor Identification Screening Improves Diagnostic Classification in Incipient Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1497-1507, 2017.
, “Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.”, J Alzheimers Dis, vol. 59, no. 2, pp. 575-590, 2017.
, “Prediction of Conversion to Alzheimer's Disease with Longitudinal Measures and Time-To-Event Data.”, J Alzheimers Dis, vol. 58, no. 2, pp. 361-371, 2017.
, “Sleep Deprivation Induced Plasma Amyloid-β Transport Disturbance in Healthy Young Adults.”, J Alzheimers Dis, vol. 57, no. 3, pp. 899-906, 2017.
, “Upregulated Expression of Heparanase and Heparanase 2 in the Brains of Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 1, pp. 185-192, 2017.
, “The Utilization of Robotic Pets in Dementia Care.”, J Alzheimers Dis, vol. 55, no. 2, pp. 569-574, 2017.
, “11C-CFT-PET in Presymptomatic FTDP-17: A Potential Biomarker Predicting Onset.”, J Alzheimers Dis, vol. 61, no. 2, pp. 613-618, 2018.
, “Aging without Dementia is Achievable: Current Evidence from Epidemiological Research.”, J Alzheimers Dis, vol. 62, no. 3, pp. 933-942, 2018.
, “Analysis of Brain Donors' Demographic and Medical Characteristics to Facilitate the Construction of a Human Brain Bank in China.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1245-1254, 2018.
, “Analysis of Brain Donors' Demographic and Medical Characteristics to Facilitate the Construction of a Human Brain Bank in China.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1245-1254, 2018.
, “Biallelic Loss of Function of SORL1 in an Early Onset Alzheimer's Disease Patient.”, J Alzheimers Dis, vol. 62, no. 2, pp. 821-831, 2018.
, “Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention.”, J Alzheimers Dis, vol. 62, no. 3, pp. 993-1012, 2018.
, “Distribution of Cerebrospinal Fluid Biomarker Profiles in Patients Explored for Cognitive Disorders.”, J Alzheimers Dis, vol. 64, no. 3, pp. 889-897, 2018.
,